Danggui Sini Decoction Alleviates Sciatica by Reducing Peripheral Sensitization through Downregulation of Transient Receptor Potential Channels in Dorsal Root Ganglions
Chinese Journal of Integrative Medicine · 2026-11 · 32 (11) · 1024-1032
DOI: 10.1007/s11655-026-4045-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Journal of Integrative Medicine, online erschienen am 03.09.2026. Verfasst von Di Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Jinan University, Guangzhou, 510632, China. Hauptthemen laut MEDLINE: Ganglia, Spinal, Drugs, Chinese Herbal, Down-Regulation, Sciatica. Die Arbeit nennt 40 Literaturangaben.
Abstract (Originalsprache)
Objective
To elucidate whether Danggui Sini Decoction (DGSD) relieves sciatica by downregulating transient receptor potential (TRP) channels involved in peripheral sensitization.
Methods
After conducting chronic constriction injury of sciatic nerve (CCI) operation, 32 SD rats, randomly assigned to the sham, CCI 7d, CCI 14d, and CCI 21d groups ( n =8 per group), were used to observe the course of sciatica. mRNA sequencing of dorsal root ganglia (DRG) was conducted on rats in the sham and CCI 21d groups. Another 32 rats were divided into the sham, CCI, mecobalamin, and DGSD groups, 8 in each group. mRNA sequencing analysis and single-cell RNA-sequencing (scRNA-seq) data analysis were conducted. Behavioural tests were conducted to evaluate the therapeutic effects of DGSD. The levels of TRP vanilloid (TRPV)1–4, TRP ankyrin 1 (TRPA1), TRP melastatin 8 (TRPM8), Ras homolog family member A (RhoA), and phosphorylated p38 mitogen-activated protein kinase (p-p38MAPK) were measured via Western blot, and the serum levels of C-C motif chemokine ligand 2 and 5 (CCL2, CCL5), substance P (SP), and prostaglandin E2 (PGE2) were conducted via ELISA. Results scRNA-seq and mRNA sequencing analysis revealed that inflammatory mediator regulation of TRP channels played a role in the development of sciatica. CCI rats exhibited cold hyperalgesia from day 4 to 21, increased the DRG protein expression levels of TRP channels, including TRPV1–4, TRPA1, TRPM8, RhoA, p-p38MAPK, CCL2, CCL5, SP, and PGE2. Treatment with DGSD decreased the serum levels of CCL2, CCL5, SP, and PGE2, and reduced the levels of RhoA, p-p38MAPK, TRPV1–4, TRPA1, and TRPM8 in DRG ( P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Traditional Chinese Medicine, Jinan University, Guangzhou, 510632, China.
- Department of Dermatology, Guangzhou Medical University Affiliated Traditional Chinese Medicine Hospital, Guangzhou, 511400, China.
- College of Traditional Chinese Medicine, Jinan University, Guangzhou, 510632, China. chenjiaxu@hotmail.com.
Zitieren
APA
Zhang, D., Zhuang, Z. F., Lin, S. Z., Chen, Z. N., Chen, H. L., Gu, J. Y., Hao, Y. T., Li, Y. X., Chen, J. X., & Zhao, G. P. (2026). Danggui Sini Decoction Alleviates Sciatica by Reducing Peripheral Sensitization through Downregulation of Transient Receptor Potential Channels in Dorsal Root Ganglions. Chinese Journal of Integrative Medicine, 32(11), 1024-1032. https://doi.org/10.1007/s11655-026-4045-8
Vancouver
Zhang D, Zhuang ZF, Lin SZ, Chen ZN, Chen HL, Gu JY, et al. Danggui Sini Decoction Alleviates Sciatica by Reducing Peripheral Sensitization through Downregulation of Transient Receptor Potential Channels in Dorsal Root Ganglions. Chinese Journal of Integrative Medicine. 2026;32(11):1024-1032. doi:10.1007/s11655-026-4045-8
BibTeX
@article{Zhang2026,
author = {Zhang, Di and Zhuang, Zi-Feng and Lin, Shao-Zi and Chen, Zen-Ni and Chen, Hong-Ling and Gu, Jun-Yan and Hao, Yu-Ting and Li, Yi-Xuan and Chen, Jia-Xu and Zhao, Guo-Ping},
title = {Danggui Sini Decoction Alleviates Sciatica by Reducing Peripheral Sensitization through Downregulation of Transient Receptor Potential Channels in Dorsal Root Ganglions},
journal = {Chinese Journal of Integrative Medicine},
year = {2026},
volume = {32},
number = {11},
pages = {1024--1032},
doi = {10.1007/s11655-026-4045-8}
}
EUVIMED